These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15734855)

  • 21. Increased body fat mass explains the positive association between circulating estradiol and insulin resistance in postmenopausal women.
    Marchand GB; Carreau AM; Weisnagel SJ; Bergeron J; Labrie F; Lemieux S; Tchernof A
    Am J Physiol Endocrinol Metab; 2018 May; 314(5):E448-E456. PubMed ID: 29208612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of aerobic exercise training on serum sex hormone binding globulin, body fat index, and metabolic syndrome factors in obese postmenopausal women.
    Kim JW; Kim DY
    Metab Syndr Relat Disord; 2012 Dec; 10(6):452-7. PubMed ID: 22989086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study.
    Leão LM; Duarte MP; Silva DM; Bahia PR; Coeli CM; de Farias ML
    Eur J Endocrinol; 2006 Jan; 154(1):131-9. PubMed ID: 16382002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance.
    Pascot A; Després JP; Lemieux I; Bergeron J; Nadeau A; Prud'homme D; Tremblay A; Lemieux S
    Diabetologia; 2000 Sep; 43(9):1126-35. PubMed ID: 11043858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between osteocalcin and metabolic syndrome in postmenopausal women.
    Lee SW; Jo HH; Kim MR; Kim JH; You YO
    Arch Gynecol Obstet; 2015 Sep; 292(3):673-81. PubMed ID: 25716667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deterioration of the metabolic risk profile in women. Respective contributions of impaired glucose tolerance and visceral fat accumulation.
    Pascot A; Després JP; Lemieux I; Alméras N; Bergeron J; Nadeau A; Prud'homme D; Tremblay A; Lemieux S
    Diabetes Care; 2001 May; 24(5):902-8. PubMed ID: 11347752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Degradation in insulin sensitivity with increasing severity of the metabolic syndrome in obese postmenopausal women.
    Karelis AD; Henry JF; St-Pierre DH; Prud'homme D; Rabasa-Lhoret R
    Diabetes Obes Metab; 2006 May; 8(3):336-41. PubMed ID: 16634994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women.
    Pascot A; Lemieux S; Lemieux I; Prud'homme D; Tremblay A; Bouchard C; Nadeau A; Couillard C; Tchernof A; Bergeron J; Després JP
    Diabetes Care; 1999 Sep; 22(9):1471-8. PubMed ID: 10480511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2005 Oct; 28(10):2472-9. PubMed ID: 16186282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers.
    Lima MM; Pareja JC; Alegre SM; Geloneze SR; Kahn SE; Astiarraga BD; Chaim ÉA; Baracat J; Geloneze B
    Obesity (Silver Spring); 2013 Mar; 21(3):E182-9. PubMed ID: 23404948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk.
    Després JP
    Obes Res; 1998 Apr; 6 Suppl 1():8S-17S. PubMed ID: 9569171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women.
    Ryan AS; Nicklas BJ; Berman DM
    Diabetes Care; 2002 Jan; 25(1):127-33. PubMed ID: 11772913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance independently influences arterial stiffness in normoglycemic normotensive postmenopausal women.
    Park JS; Nam JS; Cho MH; Yoo JS; Ahn CW; Jee SH; Lee HS; Cha BS; Kim KR; Lee HC
    Menopause; 2010 Jul; 17(4):779-84. PubMed ID: 20215975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative contribution of muscle and liver insulin resistance to dysglycemia in postmenopausal overweight and obese women: A MONET group study.
    Elisha B; Disse E; Chabot K; Taleb N; Prud'homme D; Bernard S; Rabasa-Lhoret R; Bastard JP
    Ann Endocrinol (Paris); 2017 Feb; 78(1):1-8. PubMed ID: 27931981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiometabolic risk factors in preschool children with abdominal obesity from Medellín, Colombia.
    Marín-Echeverri C; Aristizábal JC; Gallego-Lopera N; Santa-Ramírez HA; Hoyos-Gómez M; Ruiz-Pineda AM; Arias AA; Barona-Acevedo J
    J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1179-1189. PubMed ID: 30367807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Body fat distribution modulates insulin sensitivity in post-menopausal overweight and obese women: a MONET study.
    Tousignant B; Faraj M; Conus F; Garrel D; Brochu M; Rabasa-Lhoret R; Coderre L
    Int J Obes (Lond); 2008 Nov; 32(11):1626-32. PubMed ID: 18838980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adipose tissue and metabolic alterations: regional differences in fat cell size and number matter, but differently: a cross-sectional study.
    Rydén M; Andersson DP; Bergström IB; Arner P
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1870-6. PubMed ID: 24937536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on relationship between endogenous androgens and insulin resistance at the different stages of postmenopause].
    Cao YK; Zhang SF; Zou SE; Xia X; Xu LN
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):740-4. PubMed ID: 24406129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between anthropometric indicators of body fat and metabolic risk markers in post-menopausal women.
    Orsatti FL; Nahas EA; Nahas-Neto J; Maesta N; Orsatti CL; Vespoli Hde L; Traiman P
    Gynecol Endocrinol; 2010 Jan; 26(1):16-22. PubMed ID: 19701839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.